Showing results (541-550 of 635) with videos related to
Sort By:
Pageof 64
Genetics and Molecular Research : GMR|July 26, 2014
Development and characterization of microsatellite loci for Ocotea species (Lauraceae) threatened with extinctionE M Martins, G Martinelli, M P Arbetman, et al.Leukemia Research|July 20, 2018
Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasmsJ Berdeja, F Palandri, M R Baer, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer: a multicentric phase I-II studyO Pagani, C Sessa, F Nolè, et al.Leukemia & Lymphoma|September 7, 2000
Quantitative evaluation of BCR-ABL amount of transcript post mobilization with G-CSF of peripheral blood stem cells from chronic myeloid leukemia patients in cytogenetic responseG Martinelli, V Montefusco, M Amabile, et al.Ecancermedicalscience|January 26, 2012
Intensified ChlVPP/ABVVP chemotherapy regimen and pegfilgrastim support in advanced Hodgkin lymphomaE Cocorocchio, A Vanazzi, S Bassi, et al.Leukemia|October 12, 2007
Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cellsV Papa, P L Tazzari, F Chiarini, et al.European Journal of Haematology|September 21, 2000
All-trans retinoic acid significantly reduces the incidence of early hemorrhagic death during induction therapy of acute promyelocytic leukemiaG Visani, L Gugliotta, P Tosi, et al.Bone Marrow Transplantation|September 14, 1999
Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cellsG Visani, R Lemoli, P Tosi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 23, 1999
Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancerO Pagani, C Sessa, G Martinelli, et al.Leukemia|August 30, 2002
Nuclear factor-erythroid 2 (NF-E2) expression in normal and malignant megakaryocytopoiesisL Catani, N Vianelli, M Amabile, et al.Pageof 64